Pharmaceutical Regulation and Incentives for Innovation in an International Perspective

  • 19. května 2026
    16:30

Venue: Mendel Museum's Augustinian Abbey Refectory at Mendel Square

Muž v modrém saku a světlé košili, stojící před moderní budovou s nápisem SE v pozadí, s rukama zkříženými přes hrudník.

Before the lecture, there will be small refreshments at 4:00 pm. During this time, you can discuss with each other and meet the speaker.

Hosted by Jakub Hlávka, Ph.D.Director of the Health Economics, Policy and Innovation Institute (HEPII)

Pierre Dubois is a Professor of Economics at the Toulouse School of Economics (TSE), a Research Fellow of both the CEPR and of the Institute for Fiscal Studies in London. His research spans industrial organization, health and pharmaceuticals, food demand, development economics and applied econometrics, with publications in leading journals including the American Economic Review, Econometrica, and the Journal of Political Economy. He has held visiting positions at University of California, Berkeley and Northwestern University and has been visiting professor at Harvard University. He currently serves as Co-Editor of the Journal of the European Economic Association and Director of the CEPR Industrial Organization program. He has been leading the TSE Health Center since its creation in 2021, and he received an ERC Advanced Grant in 2024 on the “Economics of Health Care Markets and Innovation“.

Find more information about Professor Dubois here: https://www.tse-fr.eu/people/pierre-dubois

Abstract

This lecture examines pharmaceutical regulation and the incentives for innovation from an international perspective, highlighting the public good nature of health care innovation and its cross-border diffusion. It summarizes empirical evidence on how push and pull incentives shape R&D investment, innovation, and global access. It emphasizes the role of strategic interdependencies and spillovers, including free riding in R&D financing, learning-by-doing effects, drug shortages, reference pricing, and parallel trade. We then provide new evidence on the international spillovers of pull incentives on innovation showing that international cooperation and innovative institutions are necessary to better align national regulations with the global objective of sustaining pharmaceutical innovation.

To stay informed and ensure you don’t miss any upcoming HEPII events, please subscribe to the newsletter: https://hepii.econ.muni.cz/en/newsletter

Používáte starou verzi internetového prohlížeče. Doporučujeme aktualizovat Váš prohlížeč na nejnovější verzi.

Další info